Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ce |
RCV000998512 | SCV001154614 | likely pathogenic | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
| Human Genome Lab, |
RCV003153244 | SCV003842226 | pathogenic | Complex cortical dysplasia with other brain malformations 7 | 2022-08-03 | criteria provided, single submitter | clinical testing | The missense variant NM_178012.5(TUBB2B):c.1172G>A (p.Arg391His) causes the same amino acid change as a previously established pathogenic variant. The p.Arg391His variant is novel (not in any individuals) in 1kG All. The p.Arg391His variant is novel (not in any individuals) in gnomAD as well as in our inhouse database. The variant was previously reported in ClinVar as Likely Pathogenic (Accession:VCV000809861.14). There is a small physicochemical difference between arginine and histidine, which is not likely to impact secondary protein structure as these residues share similar properties. The gene TUBB2B has a low rate of benign missense variation as indicated by a high missense variants Z-Score of 5.12. The gene TUBB2B contains 31 pathogenic missense variants, indicating that missense variants are a common mechanism of disease in this gene. 3 variants within 6 amino acid positions of the variant p.Arg391His have been shown to be pathogenic, while none have been shown to be benign. In addition, the clinical phenotype of the proband matches with that of the disorder caused by pathogenic variants in the TUBB2B gene. For these reasons, this variant has been classified as Pathogenic. |